Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Table of Contents.
Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair.
Parametric Probability Distribution Functions for Axon Diameters of Corpus Callosum.
TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.
FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases.
Trifluoperazine: A Sprightly Old Drug.
[Experience of application of Russian biosimilar of interferon beta-1b for treatment of pediatric multiple sclerosis].
Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Neuron-Microglia Interaction Induced Bi-directional Cytotoxicity Associated with Calpain Activation.
Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study.
High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring.
Social Cognition in Multiple Sclerosis: a Meta-Analysis.
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Circulating microRNAs as biomarkers in progressive multiple sclerosis.
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.
Endocannabionoid System in Neurological Disorders.
Transverse Myelitis in Acute Hepatitis A Infection: The Rare Co-Occurrence of Hepatology and Neurology.
Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
Testing the health promotion model for adherence and quality of life in individuals with multiple sclerosis.
Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Pages